Skip to main content

Table 4 Antimicrobial susceptibility testing of MYR, ZnO, ZnO/PVA, and ZnO/PVA/MYR against C. perfringens isolates

From: Antimicrobial potential of myricetin-coated zinc oxide nanocomposite against drug-resistant Clostridium perfringens

Treatments

Inhibition zone

MIC

MBC

MYR

6.3 ± 0.213d

1024 ± 1.00a

1024 ± 1.00a

ZnO

16.00 ± 0.76c

3.6 ± 0.82c

7.20 ± 1.63c

ZnO/PVA

16.00 ± 0.76c

2.9 ± 0.69c

5.80 ± 1.37c

ZnO/PVA/MYR

30.40 ± 1.39a

0.625 ± 0.18d

1.25 ± 0.36d

IPM

21.50 ± 2.11b

13.95 ± 2.32b

21.50 ± 4.64b

p-value

 < 0.0001

 < 0.0001

 < 0.0001

  1. The inhibition zone diameters are measured by mm. Minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) values are detected by μg/mL. Breakpoints for C. perfringens susceptibility profile according to British Society for Antimicrobial Chemotherapy (BSAC) 2013 was followed for imipenem (IPM); ZnO, zinc oxoid; PVA, polyvinyl alcohol; MYR, myricetin